Latest AI and machine learning research in metabolic syndrome for healthcare professionals.
Hypertension remains the most prevalent modifiable risk factor for cardiovascular morbidity and mortality worldwide, yet rates of effective blood pressure control remain persistently suboptimal despite the availability of multiple therapeutic options. This gap reflects fundamental limitations of current care models, which rely on episodic measurements, population-based treatment algorithms, and in...
BACKGROUND AND AIMS: Cardiovascular disease is the main cause of mortality in metabolic-associated steatotic liver disease (MASLD). This study evaluated both observed and predicted cardiovascular outcomes using the Framingham risk score in a MASLD cohort and assessed subclinical atherosclerosis via carotid and femoral Doppler, along with its correlates at follow-up. METHODS: Retrospective cohort i...
Cardiovascular disease represents the leading cause of mortality in China, accounting for over 40% of all deaths. Existing risk prediction models pred...
The gut microbiome plays a vital role in maternal health and pregnancy outcomes, yet its impact on conditions like gestational hypertension (GH) and g...
Neurocritical care relies on continuous assessment of neurological function and physiology under time pressure, yet bedside teams must interpret high-...
BACKGROUND: The optic disc in a child with optic disc drusen (ODD) frequently mimics the optic disc in a child with papilledema, which may lead to unn...
Cardiopulmonary exercise testing (CPET) allows for the study of the pathophysiology of exercise intolerance through assessment of exercise integrative...
BACKGROUND: Diet-related chronic conditions are major contributors to global morbidity and mortality. Effective management of these conditions require...
Peripheral artery disease (PAD) affects more than 230 million people worldwide, with a disproportionate burden in low- and middle-income countries. PA...
AIMS: Biological age is increasingly recognized as a superior predictor of morbidity, mortality, compared with chronological age. Artificial intellige...
BACKGROUND: Hyperhomocysteinemia (HHcy) is recognized as an independent risk factor for coronary heart disease (CHD), yet accurately predicting CHD ri...
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) has been shown to be intimately linked to the presence of insulin resista...
INTRODUCTION: Aldosterone dysregulation (excess aldosterone production at the source within the adrenal glands) in the absence of primary aldosteronis...
OBJECTIVE: Management of gestational diabetes mellitus (GDM) largely follows a uniform approach, despite growing recognition of GDM heterogeneity. We ...
OBJECTIVE: Chronic pulmonary embolism (CPE) and chronic thromboembolic pulmonary hypertension (CTEPH) are challenging to diagnose, with delayed detect...
The early detection of chronic kidney disease (CKD) can lead to timely and appropriate clinical intervention. However, most CKD diagnostic systems rel...
Recent findings from the Honolulu Heart Program cohort in Hawaii suggest a longevity-associated variant of FOXO3 may provide resilience against cardio...
OBJECTIVES: This study examined patterns of clustering of intermediate risk factors for Cardiovascular diseases (CVDs) in a rural South African popula...
BACKGROUND: Cardiovascular disease (CVD) is the most prevalent complication of Type 2 Diabetes Mellitus (T2DM) and a leading cause of mortality in thi...
BACKGROUND: Achieving safe glycemic targets in intensive care remains difficult due to rapidly changing physiology, treatment effects, and measurement...